Cargando…

Meta-analysis of AKI to CKD transition in perioperative patients

BACKGROUND: Recent research shows AKI increases the risk of incident CKD. We hypothesized that perioperative AKI may confer increased risk of subsequent CKD compared to nonperioperative AKI. METHODS: A MEDLINE search was performed for “AKI, CKD, chronic renal insufficiency, surgery, and perioperativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	M. Abdala, Pedro, Swanson, Elizabeth A., P. Hutchens, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240318/ https://www.ncbi.nlm.nih.gov/pubmed/34183067 http://dx.doi.org/10.1186/s13741-021-00192-6

Ejemplares similares

Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

Dynamic signature of lymphangiogenesis during AKI and CKD
por: Zarjou, Abolfazl, et al.
Publicado: (2019)

The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023)

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease
por: Lee, Kyung, et al.
Publicado: (2022)

Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI–CKD transition
por: Hu, Zhizhi, et al.
Publicado: (2023)

Altered gut microbiome plays an important role in AKI to CKD transition in aged mice
por: Kim, Myung-Gyu, et al.
Publicado: (2023)

REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
por: Gong, Shuiqin, et al.
Publicado: (2023)

From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
por: Wang, Zhiwen, et al.
Publicado: (2022)

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
por: Kant, Sam, et al.
Publicado: (2020)

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022)

Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection
por: Song, Jianling, et al.
Publicado: (2023)

IL-18 deficiency ameliorates the progression from AKI to CKD
por: Luan, Junjun, et al.
Publicado: (2022)

EGFR drives the progression of AKI to CKD through HIPK2 overexpression
por: Xu, Luyang, et al.
Publicado: (2019)

Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation
por: Nishida, Kento, et al.
Publicado: (2021)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
por: Guan, Xu, et al.
Publicado: (2022)

A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
por: Lu, Yinghui, et al.
Publicado: (2023)

The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD
por: Kim, Dong-Hyun, et al.
Publicado: (2021)

Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
por: Chen, Jia-Huang, et al.
Publicado: (2021)

Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis
por: Yao, Mengying, et al.
Publicado: (2022)

Tubular Elabela-APJ axis attenuates ischemia-reperfusion induced acute kidney injury and the following AKI-CKD transition by protecting renal microcirculation
por: Xiong, Mingrui, et al.
Publicado: (2023)

Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012)

Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation
por: Zhu, Fengming, et al.
Publicado: (2017)

HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression
por: Zhang, Lijun, et al.
Publicado: (2023)

Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition
por: Kuang, Qing, et al.
Publicado: (2021)

Incidence and In‐Hospital Mortality of Acute Kidney Injury (AKI) and Dialysis‐Requiring AKI (AKI‐D) After Cardiac Catheterization in the National Inpatient Sample
por: Brown, Jeremiah R., et al.
Publicado: (2016)

Ischemic Duration and Frequency Determines AKI-to-CKD Progression Monitored by Dynamic Changes of Tubular Biomarkers in IRI Mice
por: Dong, Yang, et al.
Publicado: (2019)

Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice
por: Huang, Mengjie, et al.
Publicado: (2022)

Alternative polyadenylation trans-factor FIP1 exacerbates UUO/IRI-induced kidney injury and contributes to AKI-CKD transition via ROS-NLRP3 axis
por: Zheng, Tong, et al.
Publicado: (2021)

Tubular Cell Cycle Response upon AKI: Revising Old and New Paradigms to Identify Novel Targets for CKD Prevention
por: De Chiara, Letizia, et al.
Publicado: (2021)

The prognostic importance of duration of AKI: a systematic review and meta-analysis
por: Mehta, Swati, et al.
Publicado: (2018)

Prevalence and risk factors for perioperative complications of CKD patients undergoing elective hip surgery
por: You, Yongqing, et al.
Publicado: (2019)

The ICE-AKI study: Impact analysis of a Clinical prediction rule and Electronic AKI alert in general medical patients
por: Hodgson, Luke E., et al.
Publicado: (2018)

POS-465 C1Q NEPHROPATHY CAUSING ADVANCED CKD IN THE COVID 19 ERA : A PATIENT WHO RECOVERED TO BASELINE RENAL FUNCTION POST SARS-COV2 AKI ON CKD
por: BASHIR, N., et al.
Publicado: (2022)

Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score
por: Palomba, Henrique, et al.
Publicado: (2023)

Development and Feasibility of a Multidisciplinary Approach to AKI Survivorship in Care Transitions: Research Letter
por: Barreto, Erin F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s8mnict936td21eknmanj8c56q